Coronavirus

Here’s some good news for a change: the US has approved its third vaccine option–Johnson and Johnson’s single-dose shot–even as total daily vaccinations with the two-shot [...]

Much of current media coverage of the corona virus is focusing on the issue of variants of SARS-COV-2, the virus that causes COVID-19. Here in the United States, we’re currently in a race against [...]

Let’s begin with the bad news. The United States has not seen any meaningful expansion of coronavirus testing since the November 2020 fall-off (see the stall in the purple graph below). [...]

COVID-19’s Thanksgiving surge is upon us. We’re now facing record cases, hospitalizations and deaths and will continue at least through the end of January 2021. But [...]

It is a rare bit of good news we have to share in general, and especially in 2020, so we’re taking it! Less than a year after the broader world found out about an emerging new coronavirus [...]

In my latest dispatch, I discuss the resources I look at when analyzing the current snapshots of where we are in the corona pandemic, as well as where I think we’re headed this Fall and [...]

The previous two dispatches touched on the best-case scenario and the “not good” scenario, and why both indicate the public health response and the economic [...]

There are many reasons why we should not assume a vaccine will return life to normal. I discussed some of these in the first part of this dispatch on the best-case scenario. But it is more [...]

Even in the best case scenario, a coronavirus vaccine can’t be rolled out fully to the general American population until the second quarter of 2021. But that only marks the beginning of the [...]

The coronavirus epidemic in the United States continues to accelerate. Much of the recent news has been about ongoing and unprecedented caseload increases in the large states of California, Texas [...]